Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
LFWD
LFWD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LFWD News
Oramed Pharmaceuticals and Lifeward Sign Strategic Deal, Investing $9 Million
Jan 13 2026
NASDAQ.COM
Lifeward Appoints Bob Marshall as Chairman of the Board Effective January 1, 2026
Dec 19 2025
Globenewswire
Lifeward Appoints Bob Marshall as Chairman of the Board Effective January 1, 2026
Dec 19 2025
Newsfilter
Lifeward Partners with Verita Neuro to Expand ReWalk Market Access
Dec 17 2025
Newsfilter
Lifeward Secures Humana Approval for ReWalk 7 Exoskeleton
Dec 03 2025
Newsfilter
HC Wainwright & Co. Reaffirms Buy Rating on Lifeward, Adjusts Price Target to $4.5
Nov 18 2025
Benzinga
Lifeward Scheduled to Announce Third Quarter Financial Results on November 14, 2025
Nov 10 2025
Newsfilter
First Medicare Advantage Plan Offers Coverage for ReWalk 7 Personal Exoskeleton
Sep 09 2025
Newsfilter
Lifeward Secures European Authorization for New ReWalk Exoskeleton
Sep 09 2025
NASDAQ.COM
Lifeward Receives CE Mark Approval for the ReWalk 7 Personal Exoskeleton
Sep 08 2025
Newsfilter
Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership
Aug 13 2025
Newsfilter
Lifeward Names Almog Adar As CFO; Shares Rise 4% Pre-Market
Aug 13 2025
NASDAQ.COM
Lifeward to Report Second Quarter Financial Results on August 14, 2025
Aug 07 2025
Newsfilter
Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region
Aug 04 2025
Newsfilter
MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion
Jul 07 2025
Newsfilter
Lifeward Announces Closing of $2.6 Million Public Offering
Jun 26 2025
Newsfilter
Show More News
